“Molecular-Docking Study of quinazolin-4(3H)-one derivatives against GABAa Receptor Signifies the Novel Approach to Epilepsy Treatment” (2020) International Journal of Pharmaceutical Sciences and Drug Research, 12(5), pp. 572–575. doi:10.25004/IJPSDR.2020.120521.